Want to see NTRA full AI Analyst Report?

Natera (NTRA) Stock Forecast & Price Target

1,289 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

NTRA Analyst Ratings

Strong Buy

18 Buy

2 Hold

0 Sell

Based on 20 analysts giving stock ratings to

Natera

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

NTRA Stock 12 Month Forecast

Average Price Target

$339.47

▲(0.82% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $339.47 with a high forecast of $375.00 and a low forecast of $270.00. The average price target represents a 0.82% change from the last price of $336.71.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"160":"$160","214":"$214","268":"$268","322":"$322","376":"$376"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$375.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":339.47222222222223,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$339.47</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$270.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[160,214,268,322,376],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,320.76,324.9323076923077,329.1046153846154,333.2769230769231,337.4492307692308,341.6215384615385,345.7938461538462,349.9661538461538,354.1384615384615,358.3107692307692,362.4830769230769,366.6553846153846,370.8276923076923,{"y":375,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,320.76,322.1994017094017,323.63880341880343,325.0782051282051,326.5176068376068,327.95700854700857,329.39641025641026,330.83581196581196,332.27521367521365,333.7146153846154,335.1540170940171,336.5934188034188,338.03282051282054,{"y":339.47222222222223,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,320.76,316.8553846153846,312.9507692307692,309.04615384615386,305.14153846153846,301.23692307692306,297.33230769230767,293.4276923076923,289.5230769230769,285.61846153846153,281.71384615384613,277.8092307692308,273.9046153846154,{"y":270,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":169.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":161.61,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.93,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.25,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.09,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.17,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.21,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.28,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.81,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":276.27,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.76,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":320.76,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$375.00

Average Price Target$339.47

Lowest Price Target$270.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Westenberg

Piper Sandler

$363.5

Buy

7.96%

Upside

Reiterated

08/24/26

Analysts Conflicted on These Healthcare Names: Natera (NASDAQ: NTRA), Healthequity (NASDAQ: HQY) and CSPC Pharmaceutical Group (Other OTC: CHJTF)

Tycho Peterson

Jefferies

$330

Buy

-1.99%

Downside

Reiterated

08/17/26

Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG) and Natera (NASDAQ: NTRA)

‏Brendan Digan‏

Citi

$315→$365

Buy

8.40%

Upside

Reiterated

08/14/26

Natera (NTRA) Gets a Buy from Citi

Unknown Analyst

Stephens

Not Ranked

Stephens

$350

Buy

3.95%

Upside

Reiterated

08/12/26

Stephens Keeps Their Buy Rating on Natera (NTRA)

Subbu Nambi

Guggenheim

$290→$360

Buy

6.92%

Upside

Reiterated

08/11/26

Guggenheim Sticks to Their Buy Rating for Natera (NTRA)

Luke Sergott

Barclays

$260→$340

Buy

0.98%

Upside

Reiterated

08/10/26

Natera price target raised to $340 from $260 at BarclaysNatera price target raised to $340 from $260 at Barclays

Kallum Titchmarsh

Morgan Stanley

$310→$355

Buy

5.43%

Upside

Assigned

08/10/26

Natera (NTRA) Receives a Buy from Morgan Stanley

Daniel Brennan

TD Cowen

$325→$340

Buy

0.98%

Upside

Assigned

08/07/26

Analysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Natera (NTRA)

Brandon Couillard

Wells Fargo

$220→$284

Hold

-15.65%

Downside

Reiterated

08/07/26

Wells Fargo Issues a Hold Rating on Natera (NTRA)

Matt Larew

William Blair

―

Buy

―

Reiterated

08/07/26

Natera Earns Buy Rating on Surging Signatera Demand, Raised Revenue Outlook, and Multi‑Year Growth Visibility

Catherine Ramsey Schulte

Robert W. Baird

$379→$348

Buy

3.35%

Upside

Reiterated

08/07/26

Natera price target lowered to $348 from $379 at BairdNatera price target lowered to $348 from $379 at Baird

Kyle Mikson CFA

Canaccord Genuity

$330→$375

Buy

11.37%

Upside

Reiterated

08/07/26

Natera price target raised to $375 from $330 at CanaccordNatera price target raised to $375 from $330 at Canaccord

Daniel Markowitz CFA

Evercore ISI

$300→$360

Buy

6.92%

Upside

Reiterated

08/07/26

Evercore ISI Remains a Buy on Natera (NTRA)

Mark Massaro

BTIG

$290→$320

Buy

-4.96%

Downside

Reiterated

08/07/26

Natera price target raised to $320 from $290 at BTIGNatera price target raised to $320 from $290 at BTIG

Casey Woodring

J.P. Morgan

$315→$360

Buy

6.92%

Upside

Reiterated

08/07/26

J.P. Morgan Sticks to Their Buy Rating for Natera (NTRA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Westenberg

Piper Sandler

$363.5

Buy

7.96%

Upside

Reiterated

08/24/26

Analysts Conflicted on These Healthcare Names: Natera (NASDAQ: NTRA), Healthequity (NASDAQ: HQY) and CSPC Pharmaceutical Group (Other OTC: CHJTF)

Tycho Peterson

Jefferies

$330

Buy

-1.99%

Downside

Reiterated

08/17/26

Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG) and Natera (NASDAQ: NTRA)

‏Brendan Digan‏

Citi

$315→$365

Buy

8.40%

Upside

Reiterated

08/14/26

Natera (NTRA) Gets a Buy from Citi

Unknown Analyst

Stephens

Not Ranked

Stephens

$350

Buy

3.95%

Upside

Reiterated

08/12/26

Stephens Keeps Their Buy Rating on Natera (NTRA)

Subbu Nambi

Guggenheim

$290→$360

Buy

6.92%

Upside

Reiterated

08/11/26

Guggenheim Sticks to Their Buy Rating for Natera (NTRA)

Luke Sergott

Barclays

$260→$340

Buy

0.98%

Upside

Reiterated

08/10/26

Natera price target raised to $340 from $260 at BarclaysNatera price target raised to $340 from $260 at Barclays

Kallum Titchmarsh

Morgan Stanley

$310→$355

Buy

5.43%

Upside

Assigned

08/10/26

Natera (NTRA) Receives a Buy from Morgan Stanley

Daniel Brennan

TD Cowen

$325→$340

Buy

0.98%

Upside

Assigned

08/07/26

Analysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Natera (NTRA)

Brandon Couillard

Wells Fargo

$220→$284

Hold

-15.65%

Downside

Reiterated

08/07/26

Wells Fargo Issues a Hold Rating on Natera (NTRA)

Matt Larew

William Blair

―

Buy

―

Reiterated

08/07/26

Natera Earns Buy Rating on Surging Signatera Demand, Raised Revenue Outlook, and Multi‑Year Growth Visibility

Catherine Ramsey Schulte

Robert W. Baird

$379→$348

Buy

3.35%

Upside

Reiterated

08/07/26

Natera price target lowered to $348 from $379 at BairdNatera price target lowered to $348 from $379 at Baird

Kyle Mikson CFA

Canaccord Genuity

$330→$375

Buy

11.37%

Upside

Reiterated

08/07/26

Natera price target raised to $375 from $330 at CanaccordNatera price target raised to $375 from $330 at Canaccord

Daniel Markowitz CFA

Evercore ISI

$300→$360

Buy

6.92%

Upside

Reiterated

08/07/26

Evercore ISI Remains a Buy on Natera (NTRA)

Mark Massaro

BTIG

$290→$320

Buy

-4.96%

Downside

Reiterated

08/07/26

Natera price target raised to $320 from $290 at BTIGNatera price target raised to $320 from $290 at BTIG

Casey Woodring

J.P. Morgan

$315→$360

Buy

6.92%

Upside

Reiterated

08/07/26

J.P. Morgan Sticks to Their Buy Rating for Natera (NTRA)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

BLTEBelite Bio, Inc. ADR

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

3 Months

William BonelloCraig-Hallum

Success Rate

11/14 ratings generated profit

Average Return

+10.85%

Copying William Bonello's trades and holding each position for 3 Months would result in 78.57% of your transactions generating a profit, with an average return of +10.85% per trade.

1 Year

Daniel BrennanTD Cowen

Success Rate

21/21 ratings generated profit

Average Return

+63.10%

Copying Daniel Brennan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +63.10% per trade.

2 Years

Daniel BrennanTD Cowen

Success Rate

21/21 ratings generated profit

Average Return

+115.69%

Copying Daniel Brennan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +115.69% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NTRA Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, NTRA has received 28 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. NTRA average Analyst price target in the past 3 months is 339.47.

Each month's total comprises the sum of three months' worth of ratings.

NTRA Financial Forecast

NTRA Earnings Forecast

Next quarter’s earnings estimate for NTRA is -$0.22 with a range of -$0.61 to $0.13. The previous quarter’s EPS was -$0.47. NTRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Sales Forecast

Next quarter’s sales forecast for NTRA is $706.88M with a range of $676.93M to $720.00M. The previous quarter’s sales results were $752.75M. NTRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Stock Forecast FAQ

What is NTRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Natera’s 12-month average price target is 339.47.

What is NTRA’s upside potential, based on the analysts’ average price target?

Natera has 0.82% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is NTRA a Buy, Sell or Hold?

Natera has a consensus rating of Strong Buy which is based on 18 buy ratings, 2 hold ratings and 0 sell ratings.

What is Natera’s price target?

The average price target for Natera is 339.47. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $375.00 ,the lowest forecast is $270.00. The average price target represents 0.82% Increase from the current price of $336.71.

What do analysts say about Natera?

Natera’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of NTRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Natera (NTRA) Stock Forecast & Price Target

NTRA Analyst Ratings

NTRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Natera

NTRA Analyst Recommendation Trends

NTRA Financial Forecast

NTRA Earnings Forecast

NTRA Sales Forecast

NTRA Stock Forecast FAQ

Detailed List of Analyst Forecasts